RR

Rahul Ramesh

Active Director Director DIN 07991097
DIN 07991097 First appointment Dec 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 7 active board seats
Total affiliations 7 Since Dec 2017
Shareholding value •••• Premium profile

About Rahul Ramesh

Data last updated:

Rahul Ramesh is a Director at Emmar Drug Links Private Limited (since 2021), Director at Emmarlink Distributors Private Limited (since 2024) and Director at Kanhangad Links Private Limited (since 2021), and holds 4 more current directorships. The companies operate in Pharma, Chemicals and Healthcare. The 5 current companies with reported revenue have a combined latest revenue of ₹41.86 Cr; the largest is Emmar Drug Links Private Limited at ₹22.26 Cr (FY 2025).

DIN 07991097
Primary Designation Director
Industry Pharma
First Appointment 14 Dec 2017
Oldest Company Age 8 yrs
Largest company Emmar Drug Links Private Limited · ₹22.26 Cr (FY 2025)
Combined revenue ₹41.86 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Emmar Drug Links Private Limited U24299KL2021PTC068161
Director20 Mar 20212021₹22.26 Cr (FY 2025)Active
Director23 Dec 20242022₹9.72 Cr (FY 2025)Active
Kanhangad Links Private Limited U24290KL2021PTC068952
Director12 May 20212021₹8.91 Cr (FY 2025)Active
Alstonia Remedies Private Limited U74999KL2018PTC053605
Director07 Nov 20182018₹92.9 Lakh (FY 2024)Active
Route 2Land Realtors Private Limited U70100KL2018PTC051948
Director06 Feb 20182018₹3.7 Lakh (FY 2020)Active
Pvsr Creations Private Limited U74999KL2017PTC051405
Director14 Dec 20172017Under Process Of Striking Off
Designated Partner12 Dec 20192019Active

Directorship timeline

Open interactive timeline →
Qmar Lifesciences Llp
Kanhangad Links Private Limited
Emmar Drug Links Private Limited
Route 2Land Realtors Private Limited
Premium access

Shareholding and investment profile for Rahul Ramesh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rahul Ramesh

Rahul Ramesh currently holds 7 directorships: Emmar Drug Links Private Limited (Director, since 20 Mar 2021, revenue ₹22.26 Cr (FY 2025)); Emmarlink Distributors Private Limited (Director, since 23 Dec 2024, revenue ₹9.72 Cr (FY 2025)); Kanhangad Links Private Limited (Director, since 12 May 2021, revenue ₹8.91 Cr (FY 2025)); Alstonia Remedies Private Limited (Director, since 07 Nov 2018, revenue ₹92.9 Lakh (FY 2024)); Route 2Land Realtors Private Limited (Director, since 06 Feb 2018, revenue ₹3.7 Lakh (FY 2020)); and 2 more.

Rahul Ramesh was first appointed on 14 Dec 2017 as Director at Pvsr Creations Private Limited. The most recent appointment on record is 23 Dec 2024 at Emmarlink Distributors Private Limited.

The 5 current companies of Rahul Ramesh that report revenue have a combined latest revenue of ₹41.86 Cr: Emmar Drug Links Private Limited ₹22.26 Cr (FY 2025); Emmarlink Distributors Private Limited ₹9.72 Cr (FY 2025); Kanhangad Links Private Limited ₹8.91 Cr (FY 2025); Alstonia Remedies Private Limited ₹92.9 Lakh (FY 2024); Route 2Land Realtors Private Limited ₹3.7 Lakh (FY 2020).

The current boards of Rahul Ramesh's companies include Girija Ramakrishnan (Emmar Drug Links Private Limited), Praveen Damodar (Emmar Drug Links Private Limited), Ramakrishnan Makuni Varayil (Emmar Drug Links Private Limited), Rameshkumar Thinakkal Kizahaparambil (Emmar Drug Links Private Limited), Narasaiah Arigela (Emmarlink Distributors Private Limited), Rajesh Gopalakrishnan Sethulakshmi (Route 2Land Realtors Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available